Regeneron Pharmaceuticals, Inc. is an American biotechnology company based in Mount Pleasant, New York.


On August 19, 2020, Regeron announced a collaboration with Roche “on developing and manufacturing REGN-COV2”, Regeneron's experimental monoclonal antibody cocktail for use against COVID-19.1)

Bowie, A. (2020, August 19). Regenereon and Roche collaborate to significantly increase global supply of REGN-CoV2 investigational antibody cocktail for COVID-19. Regeneron Pharmaceuticals.
Back to top